|
Market Closed -
Nasdaq
16:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 20.45 USD | -0.34% |
|
-9.11% | -4.97% |
| 09-08 | Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers | RE |
| 08-07 | Regenxbio Seen on Track for Duchenne Approval as Data Strengthens, RBC Says | MT |
| Market Cap | 2.16B 1.86B 1.76B 1.6B 3B 206B 3.01B 20.93B 8.05B 105B 8.11B 7.93B 332B | P/E 2026 * |
6.56x | P/E 2027 * | 37.1x |
|---|---|---|---|---|---|
| Enterprise Value | 1.88B 1.62B 1.53B 1.39B 2.6B 179B 2.62B 18.18B 6.99B 91.19B 7.05B 6.89B 288B | EV / Sales 2026 * |
1.02x | EV / Sales 2027 * | 1.04x |
| Free-Float |
94.53% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SRPT | Delayed | |
CBOE
| SRPT | Real-time | |
|
Borsa Italiana
| 1SRPT | End-of-day quote | |
|
Tradegate
| AB3A | Real-time | |
|
Mexican S.E.
| SRPT * | End-of-day quote | |
|
Boerse Muenchen
| AB3A | Real-time | |
|
Deutsche Boerse AG
| AB3A | Delayed | |
|
Börse Stuttgart
| AB3A | Delayed | |
|
Berne S.E.
| AB3A | End-of-day quote |
Last Transcript : Sarepta Therapeutics, Inc.
| 1 day | -0.34% | ||
| 1 week | -9.11% | ||
| Current month | -2.76% | ||
| 1 month | +12.24% | ||
| 3 months | +36.33% | ||
| 6 months | +16.36% | ||
| Current year | -4.97% |
| 1 week | 19.51 |  | 23.22 |
| 1 month | 17.69 | | 23.62 |
| Current year | 14.68 | | 24.68 |
| 1 year | 14.68 | | 25.32 |
| 3 years | 10.42 | | 173.25 |
| 5 years | 10.42 | | 173.25 |
| 10 years | 10.42 | | 181.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Severino
CEO | Chief Executive Officer | 60 | 2026-07-27 |
Ryan Wong
DFI | Director of Finance/CFO | 47 | 2025-07-15 |
Ian Estepan
DFI | Director of Finance/CFO | 50 | 2020-12-13 |
| Director | Title | Age | Since |
|---|---|---|---|
M. Wilsey
CHM | Chairman | 73 | 2015-04-15 |
| Director/Board Member | 87 | 2010-05-31 | |
Richard Barry
BRD | Director/Board Member | 67 | 2015-06-01 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/4/26 | Tax | Chief Financial Officer | -13,272 | 0.0126% | ||
| 9/4/26 | Tax | General Counsel | -22,025 | 0.0209% | ||
| 9/4/26 | Tax | Chairperson | -24,799 | 0.0235% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.34% | -9.11% | +14.18% | -82.73% | 2.17B | |
| -0.69% | -6.54% | -54.21% | -64.90% | 1.42B | |
| -0.10% | -0.63% | -21.19% | -9.16% | 357M | |
| +0.23% | -2.63% | -48.73% | - | 52.64M | |
| Average | -0.23% | -3.64% | -27.49% | -52.26% | 998.2M | |
| Weighted average by Cap. | -0.44% | -6.08% | -14.06% | -69.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.84B 1.58B 1.5B 1.36B 2.55B 176B 2.56B 17.8B 6.85B 89.3B 6.9B 6.75B 282B | 1.38B 1.19B 1.13B 1.02B 1.92B 132B 1.93B 13.38B 5.15B 67.12B 5.19B 5.07B 212B |
| Net income | 366M 315M 298M 270M 507M 34.93B 510M 3.54B 1.36B 17.77B 1.37B 1.34B 56.16B | 39.41M 33.96M 32.16M 29.15M 54.68M 3.77B 54.96M 382M 147M 1.92B 148M 145M 6.05B |
| Net Debt | -284M -245M -232M -210M -394M -27.13B -396M -2.75B -1.06B -13.8B -1.07B -1.04B -43.61B | -724M -624M -590M -535M -1B -69.14B -1.01B -7.01B -2.7B -35.18B -2.72B -2.66B -111B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | US$20.45 | -0.34% | 1,810,529 |
| 26-09-10 | US$20.52 | -6.81% | 2,204,294 |
| 26-09-09 | US$22.02 | +5.16% | 4,167,542 |
| 26-09-08 | US$20.94 | -6.93% | 6,242,673 |
| 26-09-04 | US$22.50 | -2.13% | 2,955,533 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SRPT Stock
Select your edition
All financial news and data tailored to specific country editions
